DIC - Nursing Case Study

Pathophysiology

• Primary mechanism: Disseminated intravascular coagulation (DIC) begins with widespread activation of the coagulation cascade, often triggered by severe infections, trauma, or malignancies, leading to excessive thrombin generation and fibrin deposition.

• Secondary mechanism: The extensive clotting depletes platelets and coagulation factors, causing consumption coagulopathy, which results in severe bleeding due to the body's inability to sustain normal hemostasis.

• Key complication: The simultaneous occurrence of microvascular thrombosis and bleeding can lead to organ dysfunction and increased risk of mortality, emphasizing the need for early recognition and management in clinical settings.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, History of deep vein thrombosis

• Current medications: Lisinopril, Metformin, Warfarin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Bleeding gums and unusual bruising

• Key symptoms: Generalized weakness, shortness of breath, abdominal pain, confusion

• Vital signs: Blood pressure 102/65 mmHg, heart rate 110 bpm, respiratory rate 22 breaths/min, temperature 38.3°C

Section 1

Change in Patient Status:

A few hours after the initial presentation, the patient’s condition begins to deteriorate. His vital signs reveal a further drop in blood pressure to 88/58 mmHg and an increase in heart rate to 120 bpm, indicating worsening hemodynamic instability. His respiratory rate remains elevated at 24 breaths/min, and his oxygen saturation has decreased to 92% on room air. The patient is now more lethargic, responding only to verbal stimuli, and his abdominal pain has intensified, suggesting possible organ dysfunction. Upon examination, there is increased pallor and petechiae are more widespread, particularly on the arms and chest.

Laboratory results return, showing a significant drop in platelet count to 45,000/mm³, prolonged prothrombin time (PT) at 26 seconds, and activated partial thromboplastin time (aPTT) at 48 seconds. Fibrinogen levels are critically low at 100 mg/dL, and D-dimer is markedly elevated. These findings confirm the presence of acute DIC with both thrombotic and bleeding complications. The patient's kidney function tests indicate a rising creatinine level, now at 2.3 mg/dL, suggesting acute kidney injury, likely secondary to microvascular thrombi impairing renal perfusion.

These developments necessitate immediate clinical intervention. The healthcare team must prioritize stabilizing the patient's hemodynamics and addressing the underlying cause of DIC. Potential interventions include fluid resuscitation, administration of fresh frozen plasma, and platelet transfusions. Furthermore, evaluating the potential infectious or malignant trigger is critical to guide definitive treatment. As the patient’s status evolves, continuous monitoring and reassessment remain crucial, with a focus on preventing further complications such as multi-organ failure.

Section 2

New Complications:

Despite initial interventions, the patient's condition continues to worsen, signaling the development of new complications. The nursing team notes an increase in respiratory distress, characterized by a progressive decrease in oxygen saturation to 88% despite supplemental oxygen via nasal cannula. Auscultation of the lungs now reveals bilateral crackles, suggesting pulmonary edema, possibly due to acute heart failure or fluid overload from aggressive fluid resuscitation. Additionally, the patient exhibits oliguria with urine output dropping to less than 20 mL/hour, further indicating a deterioration in renal function.

Laboratory tests reveal worsening metabolic acidosis with an arterial blood gas showing a pH of 7.28, PaCO2 of 33 mmHg, and HCO3- of 16 mEq/L. Lactate levels are elevated at 5 mmol/L, indicating tissue hypoperfusion and anaerobic metabolism. The patient's mental status has also declined; he is now only responsive to painful stimuli. Transaminase levels are significantly elevated, suggesting liver dysfunction, possibly due to ischemic hepatitis from reduced perfusion. These signs point toward the progression to multi-organ dysfunction syndrome (MODS), a critical complication often associated with severe DIC and sepsis.

The healthcare team must now reassess their management approach, considering the possibility of initiating advanced organ support, such as mechanical ventilation and renal replacement therapy, while continuing to identify and treat the underlying cause of DIC. The need for a multidisciplinary approach involving critical care specialists becomes evident, as does the importance of family communication and support given the gravity of the patient's condition. Ongoing assessment and integration of new data will guide the next steps in management, aiming to stabilize the patient and prevent further deterioration.

Section 3

The nursing team, in collaboration with the critical care specialists, initiates mechanical ventilation due to the patient's increasing respiratory distress and hypoxemia. This intervention aims to improve oxygenation and decrease the work of breathing as the patient's respiratory status declines. Despite these efforts, the patient's blood pressure begins to fall, with readings dropping to 85/50 mmHg. The heart rate remains elevated at 120 bpm, indicating persistent hemodynamic instability and potential progression to shock. Continuous monitoring reveals that the patient remains poorly responsive, with a Glasgow Coma Scale score of 8, necessitating more comprehensive neurological assessment and potential neuroprotective strategies.

Further diagnostic testing is performed to better understand the ongoing deterioration. An echocardiogram reveals a reduced ejection fraction of 35%, suggesting decreased cardiac output and supporting suspicions of acute heart failure. Kidney function tests show a rise in creatinine to 3.2 mg/dL, confirming acute kidney injury. The coagulation profile remains abnormal with a further decrease in platelet count to 45,000/µL, elevated D-dimer levels, and prolonged prothrombin time, indicating ongoing disseminated intravascular coagulation. In response, the team considers escalating anticoagulation therapy while balancing the risk of bleeding.

In light of these developments, the healthcare team calls upon a multidisciplinary meeting to discuss the patient's care plan, emphasizing a coordinated effort to manage fluid balance, optimize hemodynamics, and address organ support needs. Pharmacological interventions, including the adjustment of diuretics and vasopressors, are considered to stabilize the patient's blood pressure and manage fluid overload. The team also places significant importance on regularly updating the family, ensuring they understand the current situation and potential outcomes, reinforcing the need for compassionate communication in times of critical illness. The patient's journey now hinges on close monitoring and timely adjustments to the treatment plan, aiming to prevent further complications and support recovery.

Section 4

Following the multidisciplinary meeting, the healthcare team initiates adjustments to the patient's treatment plan. Vasopressors are titrated to improve blood pressure stability, and diuretics are cautiously administered to manage fluid overload while minimizing the risk of further compromising kidney function. Despite these measures, the patient's condition continues to evolve with new complications. The patient's respiratory status remains critical as mechanical ventilation settings are optimized to enhance oxygenation, yet arterial blood gas analysis reveals persistent metabolic acidosis with a pH of 7.28, HCO3- at 18 mEq/L, and PaCO2 at 50 mmHg. These findings indicate a potential progression towards lactic acidosis, likely exacerbated by poor perfusion and ongoing tissue hypoxia.

As the clinical team closely monitors the patient's hemodynamic parameters, they notice an alarming trend: the patient's urine output significantly decreases to less than 20 mL/hr, suggesting worsening renal perfusion. Concurrently, laboratory results show an increase in lactate levels to 5.5 mmol/L, further supporting the diagnosis of systemic hypoperfusion and potential septic shock. The healthcare team reevaluates the balance between fluid resuscitation and vasopressor support, recognizing the critical need to optimize tissue perfusion while preventing fluid overload. These complications prompt a reassessment of the patient's antimicrobial regimen and consideration of advanced renal replacement therapy options, including continuous renal replacement therapy (CRRT), to manage the acute kidney injury and correct electrolyte imbalances effectively.

Faced with these new developments, the clinical team prioritizes regular reassessment and dynamic adjustment of interventions. They maintain a vigilant approach to monitoring for signs of further organ dysfunction and potential bleeding complications due to DIC. The focus remains on stabilizing the patient, mitigating the risk of additional organ failure, and continuously communicating with the patient's family. The next steps in the patient's care will depend on the response to these interventions and the ability to address the underlying causes of the patient's deteriorating condition.

Section 5

As the clinical team works diligently to address the evolving complications, the patient's condition presents new challenges. The latest diagnostic results reveal a further drop in hemoglobin levels to 6.5 g/dL, indicating potential ongoing bleeding complications associated with Disseminated Intravascular Coagulation (DIC). Coagulation studies show a markedly elevated D-dimer at 8,000 ng/mL and a prolonged prothrombin time (PT) of 24 seconds, further confirming the coagulation cascade's dysregulation. Platelet counts have also decreased significantly to 45,000/mm³, raising concerns about the risk of spontaneous bleeding and necessitating close monitoring for any signs of active hemorrhage.

In response to these findings, the healthcare team initiates a transfusion protocol to manage the critical hemoglobin levels and support hemostasis. Fresh frozen plasma and platelet transfusions are administered cautiously, balancing the need to correct coagulation abnormalities against the risk of fluid overload and transfusion-related complications. Meanwhile, the patient's hemodynamic status remains precarious. Despite adjustments to vasopressor therapy, blood pressure readings hover at 88/50 mmHg, and heart rate is persistently tachycardic at 120 beats per minute, reflecting the ongoing struggle to achieve adequate perfusion.

The clinical team also notices subtle changes in the patient's neurological status. The patient, previously responsive to verbal stimuli, now exhibits increased somnolence and a reduced response to external stimuli. These changes prompt an urgent neurologic evaluation, highlighting the need to consider cerebral hypoperfusion or potential microvascular thrombosis as contributing factors. The team remains vigilant in assessing for further deterioration and continues to adjust the treatment plan, emphasizing the importance of maintaining open communication with the patient's family to keep them informed and involved in decision-making as the patient's journey unfolds.